REQUEST A DEMO
Total
USD $0.00
Search more companies

Parexel Magyarorszag Kft. (Hungary)

Main Activities: Other Management Consulting Services
Full name: Parexel Magyarorszag Uzleti Tanacsado es Szolgaltato Kft. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

PAREXEL is a global company that operates in the healthcare industry, offering clinical development services to biopharmaceutical leaders and emerging innovators. The company's main activities include clinical trial design and delivery, regulatory services, real-world evidence generation, and patient communication and engagement. PAREXEL targets a global market with a particular emphasis on increasing access and participation in clinical research.

Headquarters
Hermina u. 17.
Budapest; Budapest; Postal Code: 1146

Contact Details: Purchase the Parexel Magyarorszag Kft. report to view the information.

Website: http://www.parexel.com

Basic Information
Total Employees:
Purchase the Parexel Magyarorszag Kft. report to view the information.
Outstanding Shares:
Purchase the Parexel Magyarorszag Kft. report to view the information.
Registered Capital:
Purchase the Parexel Magyarorszag Kft. report to view the information.
Financial Auditors:
Purchase the Parexel Magyarorszag Kft. report to view the information.
Incorporation Date:
July 27, 1998
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Parexel Magyarorszag Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
8.87%
Total operating revenue
9.62%
Operating profit (EBIT)
243.66%
EBITDA
132.27%
Net Profit (Loss) for the Period
271.29%
Total assets
11.57%
Total equity
23.77%
Operating Profit Margin (ROS)
4.88%
Net Profit Margin
4.68%
Return on Equity (ROE)
12.81%
Quick Ratio
2.17%
Cash Ratio
2.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?